Back to Journals » Drug Design, Development and Therapy » Volume 9

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]

Authors Yin Q, Li J, Xia Y, Zhang R, Guo C , Zheng Y, Chen K , Lu J, Wang J, Lu W, Li S, Liu T, Abudumijiti H, Zhou Y, Zhou Y, Chen R, Wang F

Received 14 October 2015

Accepted for publication 14 October 2015

Published 9 November 2015 Volume 2015:9 Pages 5947—5948

DOI https://doi.org/10.2147/DDDT.S98298



Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419.
 
On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear.  
 
View original article by Yin et al.



Creative Commons License © 2015 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.